HSPA8 and hepatocellular carcinoma: By clustering HCC patients from TCGA-HCC, GSE19977 and ICGC-LIRI JP based on the expression matrix of HSPA8 and DEK, we demonstrated that HCC patients with high HSPA8 expression and low DEK expression tend to have stronger immune infiltration and better sensitivity to immunotherapy.